PPT-Current Practice of Hematopoietic

Stem Cell Transplant for Primary Immunodeficiencies Nancy Bunin MD Medical Director Cell Therapy and Transplant Program Division of Oncology To DISCUSS SCID Newborn Screening Transplant controversies. 1 Hematopoietic and Lymphoid Neoplasm Coding ManualEffective with Cases Diagnosed 1/1/2010 and ForwardPublished January 2015In Appreciation Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEERMarga Stem Cell Transplantation. 2012. Summary Slides. SUM12_1.ppt. Location of Centers Participating . in the CIBMTR. 2012. SUM12_22.ppt. Slide 2. Transplants. SUM12_23.ppt. Slide . 3. Transplant Activity in the U.S.. Location of Centers Participating. in the CIBMTR 2017*. Annual Number of . HCT. Recipients in the US by Transplant Type. Allogeneic HCT Recipients in the US, by Donor Type . Allogeneic HCT Recipients in the US, by Donor Type. Changes made in 2014. Starting in 2014, there will be only one Hematopoietic Database. It will cover all of the hematopoietic diseases diagnosed from Jan. 1, 2010 forward.. Although there were changes to the MP rules, SEER is . Location of Centers Participating. in the CIBMTR 2015. Annual Number of Transplant Recipients in the US by Transplant Type. Allogeneic Transplant Recipients in the US, by Donor Type. Cumulative Plot of Transplant Recipients in the US by Transplant Type. Transplantation . Apheresis and Mobilization . Donna . F. erguson, M.D.. July 16, 2015. History . Overview. Stem cell transplantation . HPC, Apheresis . HPC, Bone marrow . Autologous . Allogeneic . Donor and recipient . Location of Centers Participating. in the CIBMTR 2014. Annual Number of Transplant Recipients in the US by Transplant Type. Transplant Recipients in the US, by Transplant and Donor Type. Cumulative Plot of Transplant Recipients in the US by Transplant Type. Location of Centers Participating. in the CIBMTR 2013. Transplant Activity in the US. Allogeneic Stem Cell Sources by Recipient Age. Autologous Stem Cell Sources by Recipient Age. Trends in Transplants. Ricerche. . Genetiche. e . Biomediche. (IRGB)/CNR. and . Humanitas Research Center. Pavia, . February. 29. th. , 2016. 1. Induced. . pluripotent. . stem. . (. iPS. ) . cells. iPSc. are . obtained by reprogramming . 23. Learning Objectives—Level I. At the end of this unit of study, the student should be able to:. Define and differentiate the terms . neoplasm. and . malignant. and identify hematopoietic disorders that can be included in each category.. At the end of this unit of study, the student should be able to:. Describe the basic concepts of cell differentiation and maturation.. Compare and contrast the categories of hematopoietic precursor cells: hematopoietic stem cells, hematopoietic progenitor cells, and maturing cells, including proliferation and differentiation potential, morphology, and population size.. A Pediatric Transplant Infectious Diseases Learning Module. Using the Modules. The modules are case-based, with decision points (branches) containing questions. Many questions don’t have right or wrong answers. Myeloid. Lymphoid. Histiocytic. Myeloid . neoplasms. (1) . Myeloproliferative. . neoplasms. (2) . Myelodysplastic. syndromes. (3) Acute myeloid leukemia. Features:. Recurrent genetic mutations. Increased bone marrow cellularity. Def: the administration of hematopoietic stem cells from any source (ex: bone marrow, peripheral blood, umbilical cord blood) to reconstitute the bone marrow.. The Nobel Prize, 1990. E. Donnall Thomas .